Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium

Gerlier, Laetitia; Lamotte, Mark; Mendes, Sofia Dos Santos; Damm, Oliver; Schwehm, Markus; Eichner, Martin

dc.contributor.author	Eichner, Martin
dc.date.accessioned	2019-01-15T14:22:04Z
dc.date.available	2019-01-15T14:22:04Z
dc.date.issued	2016
dc.identifier.issn	1179-2019
dc.identifier.uri	http://hdl.handle.net/10900/85706
dc.language.iso	en	de_DE
dc.publisher	Adis Int Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s40272-016-0180-6	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_01712
utue.publikation.seiten	303-318	de_DE
utue.personen.roh	Gerlier, Laetitia
utue.personen.roh	Lamotte, Mark
utue.personen.roh	Mendes, Sofia Dos Santos
utue.personen.roh	Damm, Oliver
utue.personen.roh	Schwehm, Markus
utue.personen.roh	Eichner, Martin
dcterms.isPartOf.ZSTitelID	Pediatric Drugs	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	18	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE